USFDA grants priority review to Sanofi-Regeneron Dupixent for bullous pemphigoid Ruchika Sharma20 Feb 2025 12:30 PM ISTParis: Sanofi has announced that the US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license...
Anti-BP180 Autoantibody Levels Linked to Bullous Pemphigoid Disease Severity: JAMA Dr Riya Dave9 Oct 2024 8:00 PM ISTResearchers reported that levels of anti-BP180 autoantibodies may be the best marker for monitoring the disease activity of bullous pemphigoid (BP)....
Low-Dose IL-2 Therapy Improves Disease Control in Bullous Pemphigoid Patients, suggests research Jacinthlyn Sylvia29 Aug 2024 5:15 AM ISTA recent study published in the Journal of the American Academy of Dermatology demonstrated that low-dose IL-2 therapy may be an effective treatment...
Rituximab and omalizumab therapy shows promise against Bullous pemphigoid: JAMA Jacinthlyn Sylvia29 Nov 2023 5:00 AM ISTThe team led by Stephanie at the University of California Davis reported a remarkable 70% durable complete response rate in a case series of 10...
Dupilumab therapy safe against Bullous Pemphigoid finds JAMA study Jacinthlyn Sylvia22 Nov 2023 4:30 PM ISTDupilumab, a potentially novel therapy for bullous pemphigoid (BP), has shown encouraging results in a retrospective cohort study conducted by the...
Study finds high incidence of bullous pemphigoid in patients undergoing chronic dialysis Medha Baranwal3 Nov 2023 10:00 PM ISTTaiwan: A recent study published in The Journal of Dermatology has revealed chronic dialysis to be an independent risk factor for the development of...
Statin use, skin infections, valvular heart disease decreases survival in patients with bullous pemphigoid Medha Baranwal5 July 2023 10:15 AM ISTGermany: A recent study published in the Indian Journal of Dermatology, Venereology and Leprology revealed that skin infections, neurological...
Teneligliptin linked to Bullous Pemphigoid: IPC Drug Safety Alert Isra Zaman3 July 2023 2:52 PM ISTThe Indian Pharmacopoeia Commission (IPC), through its recently issued drug safety alert for the month of June, has revealed that the popular...
Skin eosinophil counts correlate worse treatment responses in patients with bullous pemphigoid Medha Baranwal22 March 2023 8:00 PM ISTIsrael: A recent study in Acta Dermato-Venereologica has concluded that skin eosinophil counts in bullous pemphigoid patients are linked with worse...
Sanofi, Regeneron Pharma announce positive Phase 3 data for Dupixent in adults with uncontrolled prurigo nodularis Ruchika Sharma10 Sept 2022 12:56 PM ISTPeople with prurigo nodularis experience intense, persistent itch, with thick skin lesions (called nodules) that can cover most of the body.
Vildagliptin and linagliptin use associated with bullous pemphigoid Medha Baranwal12 Aug 2022 10:15 AM ISTJapan:A recent study in The Journal of Dermatology showed that dipeptidyl peptidase-4 inhibitors (DPP-4i) have been linked to cases of rare skin...
Rare case of childhood bullous pemphigoid mimicking toxic epidermal necrolysis: a report Medha Baranwal12 May 2022 8:30 PM ISTIran: A recent case study in the journal Case Reports in Dermatological Medicine describes the case of a childhood bullous pemphigoid (BP) that...
